1. Home
  2. ENTX vs QSG Comparison

ENTX vs QSG Comparison

Compare ENTX & QSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTX
  • QSG
  • Stock Information
  • Founded
  • ENTX 2010
  • QSG 2019
  • Country
  • ENTX Israel
  • QSG China
  • Employees
  • ENTX N/A
  • QSG N/A
  • Industry
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • QSG Other Consumer Services
  • Sector
  • ENTX Health Care
  • QSG Real Estate
  • Exchange
  • ENTX Nasdaq
  • QSG Nasdaq
  • Market Cap
  • ENTX 90.2M
  • QSG 121.6M
  • IPO Year
  • ENTX 2018
  • QSG 2023
  • Fundamental
  • Price
  • ENTX $2.30
  • QSG $2.35
  • Analyst Decision
  • ENTX Strong Buy
  • QSG
  • Analyst Count
  • ENTX 1
  • QSG 0
  • Target Price
  • ENTX $10.00
  • QSG N/A
  • AVG Volume (30 Days)
  • ENTX 83.9K
  • QSG 113.2K
  • Earning Date
  • ENTX 03-07-2025
  • QSG 03-06-2025
  • Dividend Yield
  • ENTX N/A
  • QSG 8.63%
  • EPS Growth
  • ENTX N/A
  • QSG 662.58
  • EPS
  • ENTX N/A
  • QSG 1.03
  • Revenue
  • ENTX $99,000.00
  • QSG $532,696,414.00
  • Revenue This Year
  • ENTX N/A
  • QSG N/A
  • Revenue Next Year
  • ENTX N/A
  • QSG N/A
  • P/E Ratio
  • ENTX N/A
  • QSG $2.32
  • Revenue Growth
  • ENTX 607.14
  • QSG 13.53
  • 52 Week Low
  • ENTX $0.68
  • QSG $1.47
  • 52 Week High
  • ENTX $3.35
  • QSG $6.22
  • Technical
  • Relative Strength Index (RSI)
  • ENTX 40.07
  • QSG 53.97
  • Support Level
  • ENTX $2.22
  • QSG $2.29
  • Resistance Level
  • ENTX $2.46
  • QSG $2.48
  • Average True Range (ATR)
  • ENTX 0.18
  • QSG 0.20
  • MACD
  • ENTX -0.05
  • QSG 0.04
  • Stochastic Oscillator
  • ENTX 16.07
  • QSG 75.02

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About QSG QuantaSing Group Limited

QuantaSing Group Ltd is a learning service provider in China's adult learning market for personal interest courses. It offers easy-to-understand, affordable, and accessible online courses to adult learners under various brands, including QiNiu, Kelly, and QianChi among others empowering them to pursue personal development. The company offers courses for various domains such as financial literacy, skill upgrading, recreation, and leisure which are offered in live large-class dual-instructor mode, online community-based training camp mode, and in live lecture, one-on-one tutoring mode. Its segments are; Learning service and others which derives key revenue, and Consumer business. Geographically, the company generates all of its revenue from the People's Republic of China.

Share on Social Networks: